A Phase 1/2 Trial of SRA737 in Subjects With Advanced Cancer

Clinical trial NCT02797964 · COMPLETED

Trial details

NCT number: NCT02797964
Sponsor: Sierra Oncology LLC - a GSK company
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Advanced Solid Tumors or Non-Hodgkin's Lymphoma (NHL)

Start date: 2016-07-01
Primary completion: 2019-10-28
Enrollment: 107

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.